Supervisory Animal Scientist

0910-AH27 201610 The Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions 0910 Food and Drug Administration FDA 0900 Department of Health and Human Services HHS Labeling Requirement for Approved and Conditionally Approved New Animal Drugs

FDA is proposing updated regulations for the labeling of new animal drugs and new regulations that specify the format and content of labeling for prescription (Rx) new animal products, new animal drug products for use in feed, and over-the-counter (OTC) new animal drug products. The objective of the proposed rule is to protect the health of animals by providing more drug information in a more uniform format on the animal drug label. FDA is taking this action to provide pet owners and animal health professionals more complete and consistent information about approved and conditionally approved new animal drugs.

]]> Substantive, Nonsignificant Previously Published in The Unified Agenda Proposed Rule Stage No No 21 CFR 201 21 CFR 500 21 CFR 501 21 CFR 510 21 CFR 514 21 U.S.C. 321 21 U.S.C. 331 21 U.S.C. 351 21 U.S.C. 352 21 U.S.C. 306b 21 U.S.C. 360ccc 21 U.S.C. 371 No NPRM 06/00/2017 Undetermined Undetermined Undetermined Undetermined No No Suzanne Sechen Supervisory Animal Scientist 0910 Food and Drug Administration FDA 240 402-0814 suzanne.sechen@fda.hhs.gov Center for Veterinary Medicine, 7500 Standish Place, MPN-2, HFV-137, Rockville MD 20855